sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
17-Dec-2014 14:57
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1-25 out of 943.

1 | 2 | 3 | 4 | 5 > >>

Public Release: 16-Dec-2014
Neglected disease research in Lao PDR -- capacity building in Burundi
This year, the R. Geigy Foundation in Basel, Switzerland, confers two awards: one to the Laotian scientist Somphou Sayasone, the other to the Swiss TPH Jubilee Project 'Connecting the Dots.' The value of the prizes awarded is 10,000 CHF and 70,000 CHF, respectively. With its awards the RGS recognizes excellent achievements in neglected disease research in South-East Asia and capacity building in Burundi.

Contact: Christian Heuss
christian.heuss@unibas.ch
41-612-848-683
Swiss Tropical and Public Health Institute

Public Release: 16-Dec-2014
DNDi receives US$10 million from USAID to develop new drugs for neglected filaria patients
The Drugs for Neglected Diseases initiative has been awarded US$ 10 million by the United States Agency for International Development to develop new treatments for onchocerciasis, better known as river blindness, and lymphatic filariasis, better known as elephantitis -- the first-ever USAID grant for neglected tropical disease research and development.

Contact: Violaine Dallenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 16-Dec-2014
Reproductive Sciences
Men in recovery from Ebola should wear condoms for at least 3 months
A new article reports that despite a clear lack of research on male survivors of Ebola, the current recommended practice of waiting at least three months after recovery to have unprotected sex should be upheld. This study was published today in Reproductive Sciences, a SAGE journal.

Contact: Camille Gamboa
camille.gamboa@sagepub.com
SAGE Publications

Public Release: 16-Dec-2014
Clinical Infectious Diseases
Yale researchers reveal Ebola virus spreads in social clusters
An analysis of the ongoing Ebola outbreak reveals that transmission of the virus occurs in social clusters, a finding that has ramifications for case reporting and the public health.
National Institutes of Health, Santa Fe Institute, Omidyar Group

Contact: Ziba Kashef
ziba.kashef@yale.edu
203-436-9317
Yale University

Public Release: 16-Dec-2014
PLOS Medicine
Home- versus mobile clinic-based HIV testing and counseling in rural Africa
Home- and community-based HIV testing and counselling services can achieve high participation uptake in rural Africa but reach different populations within a community and should be provided depending on the groups that are being targeted, according to new research published in this week's PLOS Medicine by Niklaus Labhardt from the Swiss Tropical and Public Health Institute, and colleagues from SolidarMed, a Swiss non-governmental Organization for Health in Africa.
SolidarMed

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 15-Dec-2014
UTMB's Sealy Center on Aging re-designated WHO/PAHO Collaborating Center
The world experts on aging research at the University of Texas Medical Branch at Galveston have again received an international designation acknowledging their special niche in an area that grows more complex every day as the elderly population explodes worldwide. UTMB's Sealy Center on Aging has been re-designated by the World Health Organization as a WHO/PAHO Collaborating Center in Aging and Health. UTMB is one of only three institutions in the United States to receive this designation.

Contact: Molly Dannenmaier
mjdannen@utmb.edu
409-772-8790
University of Texas Medical Branch at Galveston

Public Release: 15-Dec-2014
American Journal of Transplantation
Simple steps can safeguard against Ebola transmission through organ donation
While serious infections can be transmitted from donated organs, the risk of passing Ebola virus disease from an organ donor to a recipient is extremely small.

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
Wiley

Public Release: 14-Dec-2014
Potential cure for hepatitis B enters phase 1/2a clinical trial
A new treatment developed by Walter and Eliza Hall Institute researchers to promote the cure of chronic hepatitis B virus infection is now recruiting patients for a phase I/2a clinical trial.
TetraLogic Pharmaceuticals

Contact: Alan Gill
gill.a@wehi.edu.au
61-393-452-719
Walter and Eliza Hall Institute

Public Release: 12-Dec-2014
PLOS Medicine
A matter of birth and death: Unsafe conditions still killing new mothers and newborns
New publication reports that a lack of safe water, sanitation and hygiene in birth settings is killing mothers and newborns in the developing world. Call by nine leading health organizations, including the London School of Hygiene & Tropical Medicine and WaterAid, for governments to act to save lives and enable skilled health workers to do their jobs.
Sanitation and Hygiene Applied Research for Equity Consortium

Contact: Jenny Orton
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 11-Dec-2014
Science
Cause of malaria drug resistance in SE Asia identified
Malaria drug resistance in Southeast Asia is caused by a single mutated gene in the disease-causing parasite, a Columbia-led study has found.
National Institutes of Health

Contact: Lucky Tran
lt2549@cumc.columbia.edu
212-305-3689
Columbia University Medical Center

Public Release: 11-Dec-2014
International Journal of Infectious Diseases
Middle East respiratory syndrome coronavirus unlikely to reach epidemic status
In three new studies in the International Journal of Infectious Disease, researchers reported on clinical outcomes in the Kingdom of Saudi Arabia, how long patients will shed virus during their infections, and how the Sultanate of Oman is dealing with cases that have appeared there. An editorial in the same issue discusses how the relatively high percentage of infections has been hospital-acquired, which reduces the possibility that MERS-CoV will reach pandemic or even epidemic status.

Contact: Fiona Macnab
hmsmedia@elsevier.com
44-207-424-4259
Elsevier Health Sciences

Public Release: 11-Dec-2014
Scientists closing in on an new type of vaccine
When we acquire diarrhea on a vacation, it is often caused by a bacterial infection. Now a Danish research team is working on a new type of vaccine design targeting the disease causing bacterium -- if it works it may very well revolutionize not only the prevention of this disease, but also offer protection against other pathogens with a heavy disease burden such as Mycobacterium tuberculosis and antibiotic-resistant Staphylococcus aureus (MRSA). The project is supported with a 2.93 million DKK Novo Pre-Seed grant (393.677 €) from Novo Seeds, which is part of the Novo Nordisk Foundation and Novo A/S as well as the University of Southern Denmark's internal Proof of Concept Board.
Novo Nordisk Foundation, University of Southern Denmark

Contact: Birgitte Svennevig
birs@sdu.dk
University of Southern Denmark

Public Release: 11-Dec-2014
Maternal and Child Health Journal
Poor diet links obese mothers and stunted children
Malnutrition is a major cause of stunted growth in children, but new UCL research on mothers and children in Egypt suggests that the problem is not just about quantity of food but also quality.

Contact: Harry Dayantis
h.dayantis@gmail.com
44-020-310-83844
University College London

Public Release: 10-Dec-2014
Environmental Science & Technology Letters
How long can Ebola live?
The Ebola virus travels from person to person through direct contact with infected body fluids. But how long can the virus survive on glass surfaces or countertops? How long can it live in wastewater when liquid wastes from a patient end up in the sewage system? In an article published in the journal Environmental Science & Technology Letters, Kyle Bibby of the University of Pittsburgh reviews the latest research to find answers to these questions.

Contact: Cara Masset
masset@pitt.edu
412-624-4361
University of Pittsburgh

Public Release: 10-Dec-2014
Journal of Biological Chemistry
New Notre Dame study examines important Ebola protein
A new study by Robert Stahelin, an adjunct associate professor of chemistry and biochemistry at the University of Notre Dame and an associate professor at the Indiana University School of Medicine-South Bend, as well as a member of Notre Dame's Eck Institute for Global Health, investigates how the most abundant protein that composes the Ebola virus, VP 40, mediates replication of a new viral particle.

Contact: Robert Stahelin
rstaheli@nd.edu
574-631-5054
University of Notre Dame

Public Release: 9-Dec-2014
International Journal of Infectious Diseases
Guidelines for treatment of Ebola patients are urgently needed
As the Ebola Virus Diseases epidemic continues to rage in West Africa, infectious diseases experts call attention to the striking lack of treatment guidelines. With over 16,000 total cases and more than 500 new infections reported per week, and probable underreporting of both cases and fatalities, the medical community still does not have specific approved treatment in place for Ebola, according to an editorial published in the International Journal of Infectious Diseases.

Contact: Fiona Macnab
hmsmedia@elsevier.com
44-207-424-4259
Elsevier Health Sciences

Public Release: 9-Dec-2014
Lancet Infectious Diseases
Simeprevir-based therapy offers cost-effective alternative in treatment of hepatitis C
Researchers at Penn Medicine, in collaboration with an international team, have shown that a protease inhibitor, simeprevir, along with interferon and ribavirin is as effective in treating chronic Hepatitis C virus infection as telaprevir with interferon and ribavirin, the standard of care in developing countries. Further, simeprevir proved to be simpler for patients and had fewer adverse events. The complete study is online and is scheduled to publish in January 2015 in The Lancet Infectious Diseases.
Janssen Research and Development

Contact: Lee-Ann Donegan
leeann.donegan@uphs.upenn.edu
215-349-5660
University of Pennsylvania School of Medicine

Public Release: 9-Dec-2014
Bayer and DNDi sign agreement to develop an oral treatment for river blindness
Bayer HealthCare and the Drugs for Neglected Diseases initiative have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 9-Dec-2014
ACS Nano
Nanotechnology against malaria parasites
Malaria parasites invade human red blood cells; they then disrupt them and infect others. Researchers at the University of Basel and the Swiss Tropical and Public Health Institute have now developed so-called nanomimics of host cell membranes that trick the parasites. This could lead to novel treatment and vaccination strategies in the fight against malaria and other infectious diseases. Their research results have been published in the scientific journal ACS Nano.

Contact: Olivia Poisson
olivia.poisson@unibas.ch
University of Basel

Public Release: 9-Dec-2014
Genome Research
Using genome sequencing to track MRSA in under-resourced hospitals
Whole genome sequencing of MRSA from a hospital in Asia has demonstrated patterns of transmission in a resource-limited setting, where formal screening procedures are not feasible.

Contact: Sarah Collins
sarah.collins@admin.cam.ac.uk
44-012-237-65542
University of Cambridge

Public Release: 9-Dec-2014
International Journal of Epidemiology
Experts call for faster mobilization of 'overlooked' survivors to contain Ebola epidemic
In an editorial published online today in the International Journal of Epidemiology, experts from the Departments of Psychiatry and Epidemiology at Columbia University, New York, are calling for survivors of the Ebola epidemic to be mobilised in a bid to hasten containment of the disease.

Contact: Kirsty Doole
kirsty.doole@oup.com
01-865-355-439
Oxford University Press

Public Release: 9-Dec-2014
Genome Research
Genome sequencing traces MRSA spread in high transmission setting
Methicillin-resistant Staphylococcus aureus is a common cause of hospital-acquired infections, with the largest burden of infections occurring in under-resourced hospitals. While genome sequencing has previously been applied in well-resourced clinical settings to track the spread of MRSA, transmission dynamics in settings with limited infection control is unknown. In a study published online today in Genome Research, researchers used genome sequencing to understand the spread of MRSA in a resource-limited hospital with high transmission rates.
Medical Research Council, Wellcome Trust, NIHR Cambridge Biomedical Research Centre

Contact: Peggy Calicchia
calicchi@cshl.edu
516-422-4012
Cold Spring Harbor Laboratory

Public Release: 8-Dec-2014
Annals of Global Health
Asbestos: An ongoing challenge to global health
Challenges to global health can evolve from policies and decisions that take years or decades to unfold. An article in the current issue of the Annals of Global Health describes the current state of asbestos use worldwide, a story that began over 100 years ago, and the real and contrived controversies regarding asbestos.

Contact: Eileen Leahy
hmsmedia@elsevier.com
732-238-3628
Elsevier Health Sciences

Public Release: 8-Dec-2014
Each dollar spent on kids' nutrition can yield more than $100 later
There are strong economic incentives for governments to invest in early childhood nutrition, reports a new paper from the University of Waterloo and Cornell University. Published for the Copenhagen Consensus Centre, the paper reveals that every dollar spent on nutrition during the first 1,000 days of a child's life can provide a country up to $166 in future earnings.

Contact: Pamela Smyth
psmyth@uwaterloo.ca
519-888-4777
University of Waterloo

Public Release: 8-Dec-2014
Rapid Ebola test is focus of NIH grant to Rutgers scientist
Rutgers researcher David Alland, working with the California biotechnology company Cepheid, has received a grant of nearly $640,000 from the National Institutes of Health to develop a rapid test to diagnose Ebola as well as other viruses that can cause symptoms similar to Ebola. Alland and Cepheid previously used technology similar to the planned Ebola test to develop a rapid test for tuberculosis that is now widely used in impoverished areas of the world.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Rob Forman
robert.forman@rutgers.edu
973-972-7276
Rutgers University

Showing releases 1-25 out of 943.

1 | 2 | 3 | 4 | 5 > >>